-
3
-
-
12344301866
-
Epidermal differentiation: The role of proteases and their inhibitors
-
10.1078/0171-9335-00388, 15679120
-
Zeeuwen P. Epidermal differentiation: The role of proteases and their inhibitors. Eur J Cell Biol 2004, 83(11):761-773. 10.1078/0171-9335-00388, 15679120.
-
(2004)
Eur J Cell Biol
, vol.83
, Issue.11
, pp. 761-773
-
-
Zeeuwen, P.1
-
4
-
-
33646067439
-
Towards novel anti-cancer strategies based on cystatin function
-
10.1016/j.canlet.2005.04.001, 15893421
-
Keppler D. Towards novel anti-cancer strategies based on cystatin function. Cancer Lett 2006, 235(2):159-176. 10.1016/j.canlet.2005.04.001, 15893421.
-
(2006)
Cancer Lett
, vol.235
, Issue.2
, pp. 159-176
-
-
Keppler, D.1
-
5
-
-
0031030180
-
Identification, cloning, and characterization of cystatin M, a novel cysteine proteinase inhibitor, down-regulated in breast cancer
-
10.1074/jbc.272.2.903, 8995380
-
Sotiropoulou G, Anisowicz A, Sager R. Identification, cloning, and characterization of cystatin M, a novel cysteine proteinase inhibitor, down-regulated in breast cancer. J Biol Chem 1997, 272(2):903-910. 10.1074/jbc.272.2.903, 8995380.
-
(1997)
J Biol Chem
, vol.272
, Issue.2
, pp. 903-910
-
-
Sotiropoulou, G.1
Anisowicz, A.2
Sager, R.3
-
6
-
-
0030890648
-
Cystatin E is a novel human cysteine proteinase inhibitor with structural resemblance to family 2 cystatins
-
10.1074/jbc.272.16.10853, 9099741
-
Ni J, Abrahamson M, Zhang M, Fernandez MA, Grubb A, Su J, Yu GL, Li YL, Parmelee D, Xing L, et al. Cystatin E is a novel human cysteine proteinase inhibitor with structural resemblance to family 2 cystatins. J Biol Chem 1997, 272(16):10853-10858. 10.1074/jbc.272.16.10853, 9099741.
-
(1997)
J Biol Chem
, vol.272
, Issue.16
, pp. 10853-10858
-
-
Ni, J.1
Abrahamson, M.2
Zhang, M.3
Fernandez, M.A.4
Grubb, A.5
Su, J.6
Yu, G.L.7
Li, Y.L.8
Parmelee, D.9
Xing, L.10
-
7
-
-
33748041100
-
Epigenetic silencing of the tumor suppressor cystatin M occurs during breast cancer progression
-
10.1158/0008-5472.CAN-06-0576, 16912163
-
Ai LB, Kim WJ, Kim TY, Fields CR, Massoll NA, Robertson KD, Brown KD. Epigenetic silencing of the tumor suppressor cystatin M occurs during breast cancer progression. Cancer Res 2006, 66(16):7899-7909. 10.1158/0008-5472.CAN-06-0576, 16912163.
-
(2006)
Cancer Res
, vol.66
, Issue.16
, pp. 7899-7909
-
-
Ai, L.B.1
Kim, W.J.2
Kim, T.Y.3
Fields, C.R.4
Massoll, N.A.5
Robertson, K.D.6
Brown, K.D.7
-
8
-
-
33751205602
-
DNA methylation-dependent silencing of CST6 in human breast cancer cell lines
-
10.1038/labinvest.3700485, 17043665
-
Rivenbark AG, Jones WD, Coleman WB. DNA methylation-dependent silencing of CST6 in human breast cancer cell lines. Lab Invest 2006, 86(12):1233-1242. 10.1038/labinvest.3700485, 17043665.
-
(2006)
Lab Invest
, vol.86
, Issue.12
, pp. 1233-1242
-
-
Rivenbark, A.G.1
Jones, W.D.2
Coleman, W.B.3
-
9
-
-
34248324754
-
Frequent epigenetic inactivation of cystatin M in breast carcinoma
-
10.1038/sj.onc.1210107, 17099723
-
Schagdarsurengin U, Pfeifer GP, Dammann R. Frequent epigenetic inactivation of cystatin M in breast carcinoma. Oncogene 2007, 26(21):3089-3094. 10.1038/sj.onc.1210107, 17099723.
-
(2007)
Oncogene
, vol.26
, Issue.21
, pp. 3089-3094
-
-
Schagdarsurengin, U.1
Pfeifer, G.P.2
Dammann, R.3
-
10
-
-
33747889966
-
Epigenomic profiling reveals novel and frequent targets of aberrant DNA methylation-mediated silencing in malignant glioma
-
10.1158/0008-5472.CAN-05-4552, 16885346
-
Kim TY, Zhong S, Fields CR, Kim JH, Robertson KD. Epigenomic profiling reveals novel and frequent targets of aberrant DNA methylation-mediated silencing in malignant glioma. Cancer Res 2006, 66(15):7490-7501. 10.1158/0008-5472.CAN-05-4552, 16885346.
-
(2006)
Cancer Res
, vol.66
, Issue.15
, pp. 7490-7501
-
-
Kim, T.Y.1
Zhong, S.2
Fields, C.R.3
Kim, J.H.4
Robertson, K.D.5
-
11
-
-
34247373911
-
Pharmacologic inhibition of epigenetic modi. cations, coupled with gene expression profiling, reveals novel targets of aberrant DNA methylation and histone deacetylation in lung cancer
-
10.1038/sj.onc.1210041, 17043644
-
Zhong S, Fields CR, Su N, Pan YX, Robertson KD. Pharmacologic inhibition of epigenetic modi. cations, coupled with gene expression profiling, reveals novel targets of aberrant DNA methylation and histone deacetylation in lung cancer. Oncogene 2007, 26(18):2621-2634. 10.1038/sj.onc.1210041, 17043644.
-
(2007)
Oncogene
, vol.26
, Issue.18
, pp. 2621-2634
-
-
Zhong, S.1
Fields, C.R.2
Su, N.3
Pan, Y.X.4
Robertson, K.D.5
-
12
-
-
1842591219
-
Cystatin M suppresses the malignant phenotype of human MDA-MB-435S cells
-
10.1038/sj.onc.1207340, 14676833
-
Shridhar R, Zhang J, Song J, Booth BA, Kevil CG, Sotiropoulou G, Fsloane B, Keppler D. Cystatin M suppresses the malignant phenotype of human MDA-MB-435S cells. Oncogene 2004, 23(12):2206-2215. 10.1038/sj.onc.1207340, 14676833.
-
(2004)
Oncogene
, vol.23
, Issue.12
, pp. 2206-2215
-
-
Shridhar, R.1
Zhang, J.2
Song, J.3
Booth, B.A.4
Kevil, C.G.5
Sotiropoulou, G.6
Fsloane, B.7
Keppler, D.8
-
13
-
-
4944252978
-
Cystatin M: A novel candidate tumor suppressor gene for breast cancer
-
10.1158/0008-5472.CAN-04-0819, 15466187
-
Zhang J, Shridhar R, Dai Q, Song J, Barlow SC, Yin LJ, Sloane BF, Miller FR, Meschonat C, Li BDL, et al. Cystatin M: A novel candidate tumor suppressor gene for breast cancer. Cancer Res 2004, 64(19):6957-6964. 10.1158/0008-5472.CAN-04-0819, 15466187.
-
(2004)
Cancer Res
, vol.64
, Issue.19
, pp. 6957-6964
-
-
Zhang, J.1
Shridhar, R.2
Dai, Q.3
Song, J.4
Barlow, S.C.5
Yin, L.J.6
Sloane, B.F.7
Miller, F.R.8
Meschonat, C.9
Li, B.D.L.10
-
14
-
-
50249153514
-
Invasion suppressor cystatin E/M (CST6): high-level cell type-specific expression in normal brain and epigenetic silencing in gliomas
-
10.1038/labinvest.2008.66, 2574902, 18607344
-
Qiu J, Ai L, Ramachandran C, Yao B, Gopalakrishnan S, Fields CR, Delmas AL, Dyer LM, Melnick SJ, Yachnis AT, et al. Invasion suppressor cystatin E/M (CST6): high-level cell type-specific expression in normal brain and epigenetic silencing in gliomas. Lab Invest 2008, 88(9):910-925. 10.1038/labinvest.2008.66, 2574902, 18607344.
-
(2008)
Lab Invest
, vol.88
, Issue.9
, pp. 910-925
-
-
Qiu, J.1
Ai, L.2
Ramachandran, C.3
Yao, B.4
Gopalakrishnan, S.5
Fields, C.R.6
Delmas, A.L.7
Dyer, L.M.8
Melnick, S.J.9
Yachnis, A.T.10
-
15
-
-
76949096144
-
Novel targets for cystatin M/E: A new route in epidermal differentiation
-
Cheng T, Hitomi K, Ishida-Yamamoto A, van Vlijmen-Willems IM, de Jongh GJ, Bergers M, Schalkwijk J, Zeeuwen PL. Novel targets for cystatin M/E: A new route in epidermal differentiation. J Invest Dermatol 2006, 126:3-3.
-
(2006)
J Invest Dermatol
, vol.126
, pp. 3-3
-
-
Cheng, T.1
Hitomi, K.2
Ishida-Yamamoto, A.3
van Vlijmen-Willems, I.M.4
de Jongh, G.J.5
Bergers, M.6
Schalkwijk, J.7
Zeeuwen, P.L.8
-
16
-
-
33744915019
-
Cystatin M/E is a high affinity inhibitor of cathepsin V and cathepsin L by a reactive site that is distinct from the legumain-binding site - A novel clue for the role of cystatin M/E in epidermal cornification
-
10.1074/jbc.M600694200, 16565075
-
Cheng T, Hitomi K, van Vlijmen-Willems I, de Jongh GJ, Yamamoto K, Nishi K, Watts C, Reinheckel T, Schalkwijk J, Zeeuwen P. Cystatin M/E is a high affinity inhibitor of cathepsin V and cathepsin L by a reactive site that is distinct from the legumain-binding site - A novel clue for the role of cystatin M/E in epidermal cornification. J Biol Chem 2006, 281(23):15893-15899. 10.1074/jbc.M600694200, 16565075.
-
(2006)
J Biol Chem
, vol.281
, Issue.23
, pp. 15893-15899
-
-
Cheng, T.1
Hitomi, K.2
van Vlijmen-Willems, I.3
de Jongh, G.J.4
Yamamoto, K.5
Nishi, K.6
Watts, C.7
Reinheckel, T.8
Schalkwijk, J.9
Zeeuwen, P.10
-
17
-
-
0033516575
-
Inhibition of mammalian legumain by some cystatins is due to a novel second reactive site
-
10.1074/jbc.274.27.19195, 10383426
-
Alvarez-Fernandez M, Barrett AJ, Gerhartz B, Dando PM, Ni JA, Abrahamson M. Inhibition of mammalian legumain by some cystatins is due to a novel second reactive site. J Biol Chem 1999, 274(27):19195-19203. 10.1074/jbc.274.27.19195, 10383426.
-
(1999)
J Biol Chem
, vol.274
, Issue.27
, pp. 19195-19203
-
-
Alvarez-Fernandez, M.1
Barrett, A.J.2
Gerhartz, B.3
Dando, P.M.4
Ni, J.A.5
Abrahamson, M.6
-
18
-
-
33646367145
-
Identification and discrimination of extracellularly active cathepsins B and L in high-invasive melanoma cells
-
10.1016/j.ab.2006.01.037, 16620747
-
Klose A, Zigrino P, Dennhofer R, Mauch C, Hunzelmann N. Identification and discrimination of extracellularly active cathepsins B and L in high-invasive melanoma cells. Anal Biochem 2006, 353(1):57-62. 10.1016/j.ab.2006.01.037, 16620747.
-
(2006)
Anal Biochem
, vol.353
, Issue.1
, pp. 57-62
-
-
Klose, A.1
Zigrino, P.2
Dennhofer, R.3
Mauch, C.4
Hunzelmann, N.5
-
19
-
-
3042551389
-
Adenovirus-mediated expression of antisense urokinase plasminogen activator receptor and antisense cathepsin B inhibits tumor growth, invasion, and angiogenesis in gliomas
-
10.1158/0008-5472.CAN-04-1243, 15205313
-
Gondi CS, Lakka SS, Yanamandra N, Olivero WC, Dinh DH, Gujrati M, Tung CH, Weissleder R, Rao JS. Adenovirus-mediated expression of antisense urokinase plasminogen activator receptor and antisense cathepsin B inhibits tumor growth, invasion, and angiogenesis in gliomas. Cancer Res 2004, 64(12):4069-4077. 10.1158/0008-5472.CAN-04-1243, 15205313.
-
(2004)
Cancer Res
, vol.64
, Issue.12
, pp. 4069-4077
-
-
Gondi, C.S.1
Lakka, S.S.2
Yanamandra, N.3
Olivero, W.C.4
Dinh, D.H.5
Gujrati, M.6
Tung, C.H.7
Weissleder, R.8
Rao, J.S.9
-
20
-
-
2942718949
-
Inhibition of cathepsin B and MMP-9 gene expression in glioblastoma cell line via RNA interference reduces tumor cell invasion, tumor growth and angiogenesis
-
10.1038/sj.onc.1207616, 15122332
-
Lakka SS, Gondi CS, Yanamandra N, Olivero WC, Dinh DH, Gujrati M, Rao JS. Inhibition of cathepsin B and MMP-9 gene expression in glioblastoma cell line via RNA interference reduces tumor cell invasion, tumor growth and angiogenesis. Oncogene 2004, 23(27):4681-4689. 10.1038/sj.onc.1207616, 15122332.
-
(2004)
Oncogene
, vol.23
, Issue.27
, pp. 4681-4689
-
-
Lakka, S.S.1
Gondi, C.S.2
Yanamandra, N.3
Olivero, W.C.4
Dinh, D.H.5
Gujrati, M.6
Rao, J.S.7
-
21
-
-
0031884265
-
Cathepsin B and human tumor progression
-
Yan SQ, Sameni M, Sloane BF. Cathepsin B and human tumor progression. Biol Chem 1998, 379(2):113-123.
-
(1998)
Biol Chem
, vol.379
, Issue.2
, pp. 113-123
-
-
Yan, S.Q.1
Sameni, M.2
Sloane, B.F.3
-
22
-
-
0028145293
-
Cathepsin-B expression in colorectal carcinomas correlates with tumor progression and shortened patient survival
-
1887383, 7519824
-
Campo E, Munoz J, Miquel R, Palacin A, Cardesa A, Sloane BF, Emmertbuck R. Cathepsin-B expression in colorectal carcinomas correlates with tumor progression and shortened patient survival. Am J Pathol 1994, 145(2):301-309. 1887383, 7519824.
-
(1994)
Am J Pathol
, vol.145
, Issue.2
, pp. 301-309
-
-
Campo, E.1
Munoz, J.2
Miquel, R.3
Palacin, A.4
Cardesa, A.5
Sloane, B.F.6
Emmertbuck, R.7
-
23
-
-
0028113717
-
Increased gelatinase A (MMP-2) and cathepsin-B activity in invasive tumor regions of human colon-cancer samples
-
1887494, 7992833
-
Emmert-Buck MR, Roth MJ, Zhuang ZP, Campo E, Rozhin JR, Sloane BF, Liotta LA, Stetlerstevenson WG. Increased gelatinase A (MMP-2) and cathepsin-B activity in invasive tumor regions of human colon-cancer samples. Am J Pathol 1994, 145(6):1285-1290. 1887494, 7992833.
-
(1994)
Am J Pathol
, vol.145
, Issue.6
, pp. 1285-1290
-
-
Emmert-Buck, M.R.1
Roth, M.J.2
Zhuang, Z.P.3
Campo, E.4
Rozhin, J.R.5
Sloane, B.F.6
Liotta, L.A.7
Stetlerstevenson, W.G.8
-
24
-
-
0025676568
-
Cathepsin-B and its endogenous inhibitors - The role in tumor malignancy
-
10.1007/BF00049523, 2097084
-
Sloane BF, Moin K, Krepela E, Rozhin J. Cathepsin-B and its endogenous inhibitors - The role in tumor malignancy. Cancer Metastasis Rev 1990, 9(4):333-352. 10.1007/BF00049523, 2097084.
-
(1990)
Cancer Metastasis Rev
, vol.9
, Issue.4
, pp. 333-352
-
-
Sloane, B.F.1
Moin, K.2
Krepela, E.3
Rozhin, J.4
-
25
-
-
0035281687
-
Activity, expression, and transcription rate of the cathepsins B, D, H, and L in cutaneous malignant melanoma
-
10.1002/1097-0142(20010301)91:5<972::AID-CNCR1087'>3.0.CO;2-Q, 11251949
-
Frohlich E, Schlagenhauff B, Mohrle M, Weber E, Klessen C, Rassner G. Activity, expression, and transcription rate of the cathepsins B, D, H, and L in cutaneous malignant melanoma. Cancer 2001, 91(5):972-982. 10.1002/1097-0142(20010301)91:5<972::AID-CNCR1087>3.0.CO;2-Q, 11251949.
-
(2001)
Cancer
, vol.91
, Issue.5
, pp. 972-982
-
-
Frohlich, E.1
Schlagenhauff, B.2
Mohrle, M.3
Weber, E.4
Klessen, C.5
Rassner, G.6
-
26
-
-
0032126503
-
Procathepsin-L, a proteinase that cleaves human C3 (the third component of complement), confers high tumorigenic and metastatic properties to human melanoma cells
-
Frade R, Rodrigues-Lima F, Huang SY, Xie KP, Guillaume N, Bar-Eli M. Procathepsin-L, a proteinase that cleaves human C3 (the third component of complement), confers high tumorigenic and metastatic properties to human melanoma cells. Cancer Res 1998, 58(13):2733-2736.
-
(1998)
Cancer Res
, vol.58
, Issue.13
, pp. 2733-2736
-
-
Frade, R.1
Rodrigues-Lima, F.2
Huang, S.Y.3
Xie, K.P.4
Guillaume, N.5
Bar-Eli, M.6
-
27
-
-
0035870263
-
An intracellular form of cathepsin B contributes to invasiveness in cancer
-
Szpaderska AM, Frankfater A. An intracellular form of cathepsin B contributes to invasiveness in cancer. Cancer Res 2001, 61(8):3493-3500.
-
(2001)
Cancer Res
, vol.61
, Issue.8
, pp. 3493-3500
-
-
Szpaderska, A.M.1
Frankfater, A.2
-
28
-
-
0038243036
-
Overexpression of legumain in tumors is significant for invasion/metastasis and a candidate enzymatic target for prodrug therapy
-
Liu C, Sun CZ, Huang HN, Janda K, Edgington T. Overexpression of legumain in tumors is significant for invasion/metastasis and a candidate enzymatic target for prodrug therapy. Cancer Res 2003, 63(11):2957-2964.
-
(2003)
Cancer Res
, vol.63
, Issue.11
, pp. 2957-2964
-
-
Liu, C.1
Sun, C.Z.2
Huang, H.N.3
Janda, K.4
Edgington, T.5
-
29
-
-
16844367758
-
Legumain expression in relation to clinicopathologic and biological variables in colorectal cancer
-
10.1158/1078-0432.CCR-04-1642, 15788679
-
Murthy RV, Arbman G, Gao JF, Roodman GD, Sun XF. Legumain expression in relation to clinicopathologic and biological variables in colorectal cancer. Clin Cancer Res 2005, 11(6):2293-2299. 10.1158/1078-0432.CCR-04-1642, 15788679.
-
(2005)
Clin Cancer Res
, vol.11
, Issue.6
, pp. 2293-2299
-
-
Murthy, R.V.1
Arbman, G.2
Gao, J.F.3
Roodman, G.D.4
Sun, X.F.5
-
30
-
-
0034937132
-
Activation of progelatinase A by mammalian legumain, a recently discovered cysteine proteinase
-
10.1515/BC.2001.093, 11517930
-
Chen JM, Fortunato M, Stevens RAE, Barrett AJ. Activation of progelatinase A by mammalian legumain, a recently discovered cysteine proteinase. Biol Chem 2001, 382(5):777-783. 10.1515/BC.2001.093, 11517930.
-
(2001)
Biol Chem
, vol.382
, Issue.5
, pp. 777-783
-
-
Chen, J.M.1
Fortunato, M.2
Stevens, R.A.E.3
Barrett, A.J.4
-
31
-
-
49649103221
-
The gene expression profiles of primary and metastatic melanoma yields a transition point of tumor progression and metastasis
-
10.1186/1755-8794-1-13, 2408576, 18442402
-
Riker AI, Enkemann SA, Fodstad O, Liu S, Ren S, Morris C, Xi Y, Howell P, Metge B, Samant RS, et al. The gene expression profiles of primary and metastatic melanoma yields a transition point of tumor progression and metastasis. BMC Med Genomics 2008, 1:13. 10.1186/1755-8794-1-13, 2408576, 18442402.
-
(2008)
BMC Med Genomics
, vol.1
, pp. 13
-
-
Riker, A.I.1
Enkemann, S.A.2
Fodstad, O.3
Liu, S.4
Ren, S.5
Morris, C.6
Xi, Y.7
Howell, P.8
Metge, B.9
Samant, R.S.10
-
32
-
-
0029061997
-
Quantitative correlation between HLA class-I allele expression and recognition of melanoma-cells by antigen-specific cytotoxic T-lymphocytes
-
2248458, 7541714
-
Rivoltini L, Barracchini KC, Viggiano V, Kawakami Y, Smith A, Mixon A, Restifo NP, Topalian SL, Simonis TB, Rosenberg SA, et al. Quantitative correlation between HLA class-I allele expression and recognition of melanoma-cells by antigen-specific cytotoxic T-lymphocytes. Cancer Res 1995, 55(14):3149-3157. 2248458, 7541714.
-
(1995)
Cancer Res
, vol.55
, Issue.14
, pp. 3149-3157
-
-
Rivoltini, L.1
Barracchini, K.C.2
Viggiano, V.3
Kawakami, Y.4
Smith, A.5
Mixon, A.6
Restifo, N.P.7
Topalian, S.L.8
Simonis, T.B.9
Rosenberg, S.A.10
-
33
-
-
0032928064
-
Natural variation of the expression of HLA and endogenous antigen modulates ctl recognition in an in vitro melanoma model
-
10.1002/(SICI)1097-0215(19990301)80:5<781::AID-IJC24>3.0.CO;2-A, 2072935, 10048982
-
Cormier JN, Panelli MC, Hackett JA, Bettinotti MP, Mixon A, Wunderlich J, Parker LL, Restifo NP, Ferrone S, Marincola FM. Natural variation of the expression of HLA and endogenous antigen modulates ctl recognition in an in vitro melanoma model. Int J Cancer 1999, 80(5):781-790. 10.1002/(SICI)1097-0215(19990301)80:5<781::AID-IJC24>3.0.CO;2-A, 2072935, 10048982.
-
(1999)
Int J Cancer
, vol.80
, Issue.5
, pp. 781-790
-
-
Cormier, J.N.1
Panelli, M.C.2
Hackett, J.A.3
Bettinotti, M.P.4
Mixon, A.5
Wunderlich, J.6
Parker, L.L.7
Restifo, N.P.8
Ferrone, S.9
Marincola, F.M.10
-
34
-
-
0029126417
-
Establishment and characterization of an uveal-melanoma cell-line
-
10.1002/ijc.2910620208, 7622289
-
de Waard-Siebinga I, Blom DJR, Griffioen M, Schrier PI, Hoogendoorn E, Beverstock G, Danen EHJ, Jager MJ. Establishment and characterization of an uveal-melanoma cell-line. Int J Cancer 1995, 62(2):155-161. 10.1002/ijc.2910620208, 7622289.
-
(1995)
Int J Cancer
, vol.62
, Issue.2
, pp. 155-161
-
-
de Waard-Siebinga, I.1
Blom, D.J.R.2
Griffioen, M.3
Schrier, P.I.4
Hoogendoorn, E.5
Beverstock, G.6
Danen, E.H.J.7
Jager, M.J.8
-
35
-
-
0029851043
-
Brain metastasis model in athymic nude mice using a novel MUC1-secreting human breast-cancer cell line, MA11
-
10.1002/(SICI)1097-0215(19961127)68:5<682::AID-IJC20>3.0.CO;2-2, 8938153
-
Rye PD, Norum L, Olsen DR, GarmanVik S, Kaul S, Fodstad O. Brain metastasis model in athymic nude mice using a novel MUC1-secreting human breast-cancer cell line, MA11. Int J Cancer 1996, 68(5):682-687. 10.1002/(SICI)1097-0215(19961127)68:5<682::AID-IJC20>3.0.CO;2-2, 8938153.
-
(1996)
Int J Cancer
, vol.68
, Issue.5
, pp. 682-687
-
-
Rye, P.D.1
Norum, L.2
Olsen, D.R.3
GarmanVik, S.4
Kaul, S.5
Fodstad, O.6
-
36
-
-
3543009588
-
The epidermal growth factor receptor (EGFR) and proline rich tyrosine kinase 2 (PYK2) are involved in tissue factor dependent factor VIIa signalling in HaCaT cells
-
Wiiger MT, Prydz H. The epidermal growth factor receptor (EGFR) and proline rich tyrosine kinase 2 (PYK2) are involved in tissue factor dependent factor VIIa signalling in HaCaT cells. Thrombosis and Haemostasis 2004, 92(1):13-22.
-
(2004)
Thrombosis and Haemostasis
, vol.92
, Issue.1
, pp. 13-22
-
-
Wiiger, M.T.1
Prydz, H.2
-
37
-
-
0017184389
-
Rapid and sensitive method for quantification of microgram quantities of protein utilizing principle of protein-dye binding
-
10.1016/0003-2697(76)90527-3, 942051
-
Bradford MM. Rapid and sensitive method for quantification of microgram quantities of protein utilizing principle of protein-dye binding. Anal Biochem 1976, 72(1-2):248-254. 10.1016/0003-2697(76)90527-3, 942051.
-
(1976)
Anal Biochem
, vol.72
, Issue.1-2
, pp. 248-254
-
-
Bradford, M.M.1
-
38
-
-
0023784037
-
Production, characterization and use of monoklonal-antibodies against the major extracellular human cysteine proteinase-inhibitors cystatin-C and kininogen
-
10.3109/00365518809085775, 3064278
-
Olafsson I, Lofberg H, Abrahamson M, Grubb A. Production, characterization and use of monoklonal-antibodies against the major extracellular human cysteine proteinase-inhibitors cystatin-C and kininogen. Scand J Clin Lab Invest 1988, 48(6):573-582. 10.3109/00365518809085775, 3064278.
-
(1988)
Scand J Clin Lab Invest
, vol.48
, Issue.6
, pp. 573-582
-
-
Olafsson, I.1
Lofberg, H.2
Abrahamson, M.3
Grubb, A.4
-
39
-
-
0037300636
-
Cystatins C, E/M and F in human pleural fluids of patients with neoplastic and inflammatory lung disorders
-
10.1515/BC.2003.031, 12675521
-
Werle B, Sauckel K, Nathanson CM, Bjarnadottir M, Spiess E, Ebert W, Abrahamson M. Cystatins C, E/M and F in human pleural fluids of patients with neoplastic and inflammatory lung disorders. Biol Chem 2003, 384(2):281-287. 10.1515/BC.2003.031, 12675521.
-
(2003)
Biol Chem
, vol.384
, Issue.2
, pp. 281-287
-
-
Werle, B.1
Sauckel, K.2
Nathanson, C.M.3
Bjarnadottir, M.4
Spiess, E.5
Ebert, W.6
Abrahamson, M.7
-
40
-
-
0032544743
-
Cystatin F is a glycosylated human low molecular weight cysteine proteinase inhibitor
-
10.1074/jbc.273.38.24797, 9733783
-
Ni J, Fernandez MA, Danielsson L, Chillakuru RA, Zhang JL, Grubb A, Su J, Gentz R, Abrahamson M. Cystatin F is a glycosylated human low molecular weight cysteine proteinase inhibitor. J Biol Chem 1998, 273(38):24797-24804. 10.1074/jbc.273.38.24797, 9733783.
-
(1998)
J Biol Chem
, vol.273
, Issue.38
, pp. 24797-24804
-
-
Ni, J.1
Fernandez, M.A.2
Danielsson, L.3
Chillakuru, R.A.4
Zhang, J.L.5
Grubb, A.6
Su, J.7
Gentz, R.8
Abrahamson, M.9
-
41
-
-
0029744913
-
Mouse and rat cystatin C: Escherichia coli production, characterization and tissue distribution
-
10.1016/0305-0491(96)00025-9, 8761177
-
Hakansson K, Huh C, Grubb A, Karlsson S, Abrahamson M. Mouse and rat cystatin C: Escherichia coli production, characterization and tissue distribution. Comp Biochem Physiol B-Biochem Mol Biol 1996, 114(3):303-311. 10.1016/0305-0491(96)00025-9, 8761177.
-
(1996)
Comp Biochem Physiol B-Biochem Mol Biol
, vol.114
, Issue.3
, pp. 303-311
-
-
Hakansson, K.1
Huh, C.2
Grubb, A.3
Karlsson, S.4
Abrahamson, M.5
-
42
-
-
0027242118
-
Human cystatin-D - cDNA cloning, characterization of the Escherichia-coli expressed inhibitor, and identification of the native protein in saliva
-
Freije JP, Balbin M, Abrahamson M, Velasco G, Dalboge H, Grubb A, Lopezotin C. Human cystatin-D - cDNA cloning, characterization of the Escherichia-coli expressed inhibitor, and identification of the native protein in saliva. J Biol Chem 1993, 268(21):15737-15744.
-
(1993)
J Biol Chem
, vol.268
, Issue.21
, pp. 15737-15744
-
-
Freije, J.P.1
Balbin, M.2
Abrahamson, M.3
Velasco, G.4
Dalboge, H.5
Grubb, A.6
Lopezotin, C.7
-
43
-
-
0018307692
-
Use of avidin-biotin interaction in immunoenzymatic techniques
-
Guesdon JL, Ternynck T, Avrameas S. Use of avidin-biotin interaction in immunoenzymatic techniques. J Histochem Cytochem 1979, 27(8):1131-1139.
-
(1979)
J Histochem Cytochem
, vol.27
, Issue.8
, pp. 1131-1139
-
-
Guesdon, J.L.1
Ternynck, T.2
Avrameas, S.3
-
44
-
-
0030992979
-
Cloning, isolation, and characterization of mammalian legumain, an asparaginyl endopeptidase
-
10.1074/jbc.272.12.8090, 9065484
-
Chen JM, Dando PM, Rawlings ND, Brown MA, Young NE, Stevens RA, Hewitt E, Watts C, Barrett AJ. Cloning, isolation, and characterization of mammalian legumain, an asparaginyl endopeptidase. J Biol Chem 1997, 272(12):8090-8098. 10.1074/jbc.272.12.8090, 9065484.
-
(1997)
J Biol Chem
, vol.272
, Issue.12
, pp. 8090-8098
-
-
Chen, J.M.1
Dando, P.M.2
Rawlings, N.D.3
Brown, M.A.4
Young, N.E.5
Stevens, R.A.6
Hewitt, E.7
Watts, C.8
Barrett, A.J.9
-
45
-
-
0033543510
-
Colorimetric and fluorimetric microplate assays for legumain and a staining reaction for detection of the enzyme after electrophoresis
-
10.1006/abio.1999.4221, 10469498
-
Johansen HT, Knight CG, Barrett AJ. Colorimetric and fluorimetric microplate assays for legumain and a staining reaction for detection of the enzyme after electrophoresis. Anal Biochem 1999, 273(2):278-283. 10.1006/abio.1999.4221, 10469498.
-
(1999)
Anal Biochem
, vol.273
, Issue.2
, pp. 278-283
-
-
Johansen, H.T.1
Knight, C.G.2
Barrett, A.J.3
-
46
-
-
0029257305
-
Assessment of cathepsin-L activity by use of the inhibitor CA-074 compared to cathepsin-B activity in human lung tumor-tissue
-
Werle B, Ebert W, Klein W, Spiess E. Assessment of cathepsin-L activity by use of the inhibitor CA-074 compared to cathepsin-B activity in human lung tumor-tissue. Biol Chem Hoppe-Seyler 1995, 376(3):157-164.
-
(1995)
Biol Chem Hoppe-Seyler
, vol.376
, Issue.3
, pp. 157-164
-
-
Werle, B.1
Ebert, W.2
Klein, W.3
Spiess, E.4
-
47
-
-
0019765848
-
Cathepsin-B, Cathepsin-H, and Cathepsin-L
-
full_text, 7043200
-
Barrett AJ, Kirschke H. Cathepsin-B, Cathepsin-H, and Cathepsin-L. Methods Enzymol 1981, 80:535-561. full_text, 7043200.
-
(1981)
Methods Enzymol
, vol.80
, pp. 535-561
-
-
Barrett, A.J.1
Kirschke, H.2
-
48
-
-
0036538799
-
Legumain from bovine kidney: its purification, molecular cloning, immunohistochemical localization and degradation of annexin II and vitamin D-binding protein
-
Yamane T, Takeuchi K, Yamamoto Y, Li YH, Fujiwara M, Nishi K, Takahashi S, Ohkubo I. Legumain from bovine kidney: its purification, molecular cloning, immunohistochemical localization and degradation of annexin II and vitamin D-binding protein. Biochim Biophys Acta 2002, 1596(1):108-120.
-
(2002)
Biochim Biophys Acta
, vol.1596
, Issue.1
, pp. 108-120
-
-
Yamane, T.1
Takeuchi, K.2
Yamamoto, Y.3
Li, Y.H.4
Fujiwara, M.5
Nishi, K.6
Takahashi, S.7
Ohkubo, I.8
-
49
-
-
0035018513
-
Cystatin M/E expression is restricted to differentiated epidermal keratinocytes and sweat glands: a new skin-specific proteinase inhibitor that is a target for cross-linking by transglutaminase
-
10.1046/j.1523-1747.2001.01309.x, 11348457
-
Zeeuwen P, van Vlijmen-Willems I, Jansen BJH, Sotiropoulou G, Curfs JH, Meis J, Janssen JJM, van Ruissen F, Schalkwijk J. Cystatin M/E expression is restricted to differentiated epidermal keratinocytes and sweat glands: a new skin-specific proteinase inhibitor that is a target for cross-linking by transglutaminase. J Invest Dermatol 2001, 116(5):693-701. 10.1046/j.1523-1747.2001.01309.x, 11348457.
-
(2001)
J Invest Dermatol
, vol.116
, Issue.5
, pp. 693-701
-
-
Zeeuwen, P.1
van Vlijmen-Willems, I.2
Jansen, B.J.H.3
Sotiropoulou, G.4
Curfs, J.H.5
Meis, J.6
Janssen, J.J.M.7
van Ruissen, F.8
Schalkwijk, J.9
-
50
-
-
0036064858
-
Cystatin M/E expression in inflammatory and neoplastic skin disorders
-
10.1046/j.1365-2133.2002.04785.x, 12100189
-
Zeeuwen P, Van Vlijmen-Willems I, Egami H, Schalkwijk J. Cystatin M/E expression in inflammatory and neoplastic skin disorders. Br J Dermatol 2002, 147(1):87-94. 10.1046/j.1365-2133.2002.04785.x, 12100189.
-
(2002)
Br J Dermatol
, vol.147
, Issue.1
, pp. 87-94
-
-
Zeeuwen, P.1
Van Vlijmen-Willems, I.2
Egami, H.3
Schalkwijk, J.4
-
51
-
-
0034528474
-
Activation of human prolegumain by cleavage at a C-terminal asparagine residue
-
10.1042/0264-6021:3520327, 1221463, 11085925
-
Chen JM, Fortunato M, Barrett AJ. Activation of human prolegumain by cleavage at a C-terminal asparagine residue. Biochem J 2000, 352:327-334. 10.1042/0264-6021:3520327, 1221463, 11085925.
-
(2000)
Biochem J
, vol.352
, pp. 327-334
-
-
Chen, J.M.1
Fortunato, M.2
Barrett, A.J.3
-
52
-
-
21044432199
-
Asparagine endopeptidase is not essential for class II MHC antigen presentation but is required for processing of cathepsin L in mice
-
Maehr R, Hang HC, Mintern JD, Kim YM, Cuvillier A, Nishimura M, Yamada K, Shirahama-Noda K, Hara-Nishimura I, Ploegh HL. Asparagine endopeptidase is not essential for class II MHC antigen presentation but is required for processing of cathepsin L in mice. Journal of Immunology 2005, 174(11):7066-7074.
-
(2005)
Journal of Immunology
, vol.174
, Issue.11
, pp. 7066-7074
-
-
Maehr, R.1
Hang, H.C.2
Mintern, J.D.3
Kim, Y.M.4
Cuvillier, A.5
Nishimura, M.6
Yamada, K.7
Shirahama-Noda, K.8
Hara-Nishimura, I.9
Ploegh, H.L.10
-
53
-
-
0038206459
-
Upregulation of cystatin M during the progression of oropharyngeal squamous cell carcinoma from primary tumor to metastasis
-
10.1016/S1368-8375(03)00038-1, 12798398
-
Vigneswaran N, Wu J, Zacharias W. Upregulation of cystatin M during the progression of oropharyngeal squamous cell carcinoma from primary tumor to metastasis. Oral Oncol 2003, 39(6):559-568. 10.1016/S1368-8375(03)00038-1, 12798398.
-
(2003)
Oral Oncol
, vol.39
, Issue.6
, pp. 559-568
-
-
Vigneswaran, N.1
Wu, J.2
Zacharias, W.3
-
54
-
-
30544439044
-
Silencing of cystatin M in metastatic oral cancer cell line MDA-686Ln by siRNA increases cysteine proteinases and legumain activities, cell proliferation and in vitro invasion
-
10.1016/j.lfs.2005.05.096, 16150465
-
Vigneswaran N, Wu J, Nagaraj N, James R, Zeeuwen P, Zacharias W. Silencing of cystatin M in metastatic oral cancer cell line MDA-686Ln by siRNA increases cysteine proteinases and legumain activities, cell proliferation and in vitro invasion. Life Sci 2006, 78(8):898-907. 10.1016/j.lfs.2005.05.096, 16150465.
-
(2006)
Life Sci
, vol.78
, Issue.8
, pp. 898-907
-
-
Vigneswaran, N.1
Wu, J.2
Nagaraj, N.3
James, R.4
Zeeuwen, P.5
Zacharias, W.6
-
55
-
-
49749117101
-
Over-expression of cysteine proteinase inhibitor cystatin 6 promotes pancreatic cancer growth
-
10.1111/j.1349-7006.2008.00869.x, 18754876
-
Hosokawa M, Kashiwaya K, Eguchi H, Ohigashi H, Ishikawa O, Furihata M, Shinomura Y, Imai K, Nakamura Y, Nakagawa H. Over-expression of cysteine proteinase inhibitor cystatin 6 promotes pancreatic cancer growth. Cancer Sci 2008, 99(8):1626-1632. 10.1111/j.1349-7006.2008.00869.x, 18754876.
-
(2008)
Cancer Sci
, vol.99
, Issue.8
, pp. 1626-1632
-
-
Hosokawa, M.1
Kashiwaya, K.2
Eguchi, H.3
Ohigashi, H.4
Ishikawa, O.5
Furihata, M.6
Shinomura, Y.7
Imai, K.8
Nakamura, Y.9
Nakagawa, H.10
|